Journal of Bone Metabolism · 2019 · 23 citations · 28 references
MedicineEndocrinologyToxicologyBone MetabolismMineral MetabolismReproductive EndocrinologyBone EndocrinologyBone HealthBone PhysiologyBone TurnoverEndocrine ToxicityRodent EndocrinologyBone Mineral DensityEstrogen ExposureOsteocalcin Biology
BACKGROUND: The molecular pathways of how endocrine disruptors affect bone mineral density (BMD) and bone remodeling are still unclear. The purpose of this experimental study is to determine the effects of di(2-ethylhexyl)phthalate (DEHP) on bone metabolism in ovariectomized mice. METHODS: Twenty-six-month-old female CD-1 mice were divided into 4 groups: control, low-dose DEHP, high-dose DEHP, and estrogen groups (n=5, each group). All mice were subjected to ovariectomy for the induction of artificial menopause and then exposed to corn oil, DEHP, and estrogen for 2 months. Micro-computed tomography (Micro-CT) of the bone and analysis of blood samples for bone markers were performed to observe the changes in bone metabolism. RESULTS: <0.05). It means the progression of osteoporosis in the high-dose DEHP group. CONCLUSIONS: These results confirm the negative effects of DEHP on bone health in ovariectomized mice. Further continuous studies on genetic pathways and other endocrine disruptors will be necessary to validate these findings.
28
The estrogenic activity of phthalate esters in vitro.
Catherine A. Harris, Pirkko Henttu, Malcolm G. Parker et al. · Environmental Health Perspectives · 1997 · 803 citations · Full text
Activation of PPAR and PPAR by Environmental Phthalate Monoesters
C. H. Hurst, David J. Waxman · Toxicological Sciences · 2003 · 501 citations
Pharmacy, Biochemistry, Toxicology +16